Invited Commentary

Commentary on “An Updated Approach to Evaluation and Treatment of Helicobacter pylori Infection”

Authors: Patrick G. Brady, MD


This issue of the Southern Medical Journal contains an important and timely review of Helicobacter pylori diagnosis and treatment.1 Since its discovery in 1983, H. pylori infection has been found to be the main cause of peptic ulcer disease, chronic gastritis, gastric cancer, and mucosa-associated lymphoid tissue lymphoma.
Posted in: Infectious Disease90 Prevention of Infectious Disease2

This content is limited to qualifying members.

Existing members, please login first.

If you have an existing account please login now to access this article or view your purchase options.

Purchase only this article ($15)

Create a free account, then purchase this article to download or access it online for 24 hours.

Purchase an SMJ online subscription ($75)

Create a free account, then purchase a subscription to get complete access to all articles for a full year.

Purchase a membership plan (fees vary)

Premium members can access all articles plus recieve many more benefits. View all membership plans and benefit packages.


1. Lloyd BR, Leiman DA. An updated approach to evaluation and treatment of Helicobacter pylori infection. South Med J 2019;112:392-398.
2. Hooi JKY, Lai WY, Ng WK, et al. Global prevalence of Helicobacter pylori infection: systemic review and meta-analysis. Gastroenterology 2017;153:420-429.
3. Chey WD, Leontiadis GI, Howden CW, et al. ACG Clinical Guideline: treatment of Helicobacter pylori infection. Am J Gastroenterol 2017;112:212-239.
4. Malfertheiner P, Megraud F, O’Morain CA, et al. Management of Helicobacter pylori infection-the Maastricht V/Florence Consensus Report. Gut 2017;66:6-30.
5. Rubin J, Lai A, Dulai P, et al. Low rates of H. pylori eradication testing and cure rates in usual care. Gastroenterology 2018;154:S503-S504.
6. Shiota S, Reddy R, Alsarraj A, et al. Antibiotic resistance of Helicobacter pylori among male United States veterans. Clin Gastroenterol Hepatol 2015;13:1616-1624.
7. Liou JM, Chen PY, Luo JC, et al. Efficacies of genotypic resistance-guided vs empirical therapy for refractory Helicobacter pylori infection. Gastroenterology 2018;155:1109-1119.